ALTIMMUNE, INC. Restructuring Charges
ALTIMMUNE, INC. (ALT) reported Restructuring Charges of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2017-03-14
- ALTIMMUNE, INC. restructuring charges for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. restructuring charges for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. restructuring charges for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. restructuring charges for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. restructuring charges for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- ALTIMMUNE, INC. restructuring charges for fiscal 2015 was $2.55M.
- ALTIMMUNE, INC. restructuring charges for fiscal 2014 was $0.00.
- ALTIMMUNE, INC. restructuring charges for fiscal 2013 was $0.00.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 derived: sum of 2 quarters · filed 2017-03-14 | $0.00 derived: sum of 3 quarters · filed 2017-03-14 | $0.00 10-K · filed 2017-03-14 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $0.00 10-Q · filed 2016-11-04 | $26.89K derived: sum of 4 quarters · filed 2017-03-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | $26.89K derived: sum of 3 quarters · filed 2017-03-14 | $449.37K derived: sum of 4 quarters · filed 2017-03-14 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $26.89K derived: sum of 2 quarters · filed 2017-03-14 | $449.37K derived: sum of 3 quarters · filed 2017-03-14 | $485.35K derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-12-31 | $26.89K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $449.37K derived: sum of 2 quarters · filed 2017-03-14 | $485.35K derived: sum of 3 quarters · filed 2017-03-14 | $2.55M 10-K · filed 2017-03-14 |
| 2015-09-30 | $422.48K 10-Q · filed 2016-11-04 | $458.46K derived: sum of 2 quarters · filed 2016-11-04 | $2.52M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $35.98K 10-Q · filed 2016-08-04 | $2.10M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $2.06M 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |